Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer

BACKGROUND: Prioritization of breast cancer patients based on the risk of resistance to tamoxifen plays a significant role in personalized therapeutic planning and improving disease course and outcomes. METHODS: In this work, we demonstrate that a genome-wide pathway-centric computational framework...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahem, Sarra M., Epsi, Nusrat J., Coffman, Frederick D., Mitrofanova, Antonina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585053/
https://www.ncbi.nlm.nih.gov/pubmed/33099086
http://dx.doi.org/10.1016/j.ebiom.2020.103047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585053/
https://www.ncbi.nlm.nih.gov/pubmed/33099086
http://dx.doi.org/10.1016/j.ebiom.2020.103047

Ejemplares similares